Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD,

Published byMargaret Evangeline McDonald Modified over 6 years ago

Similar presentations

Presentation on theme: "Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD,"— Presentation transcript:

1 Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD, Joël Pinc , PhD, Robert Larbuisson, MD, PhD, Francine Blaffart, RN, Raymond Limet, MD, PhD  The Annals of Thoracic Surgery  Volume 69, Issue 4, Pages (April 2000) DOI: /S (00)

2 Fig 1 Postoperative blood loss after 24 hours. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

3 Fig 2 TNF-α concentration. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin. T1 = after the induction of anesthesia; T2 = 5 minutes after aorta unclamping; T3 = after protamine administration; T4 = 24 hours after protamin administration.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

4 Fig 3 IL-6 concentration. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin. T1 = after the induction of anesthesia; T2 = 5 minutes after aorta unclamping; T3 = after protamine administration; T4 = 24 hours after protamine administration.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

5 Fig 4 IL-8 concentration. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin. T1 = after the induction of anesthesia; T2 = 5 minutes after aorta unclamping; T3 = after protamine administration; T4 = 24 hours after protamine administration.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

6 Fig 5 MPO concentration. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin. T1 = after the induction of anesthesia; T2 = 5 minutes after aorta unclamping; T3 = after protamine administration; T4 = 24 hours after protamine administration.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

7 Fig 6 Elastase concentration. (HCO-A = heparin-coated group with aprotinin; HCO = heparin-coated group without aprotinin; C-A = uncoated group with aprotinin; C = uncoated group without aprotinin. T1 = after the induction of anesthesia; T2 = 5 minutes after aorta unclamping; T3 = after protamine administration; T4 = 24 hours after protamine administration.) The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration  Jean-Olivier Defraigne, MD, PhD,"

Similar presentations

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.
Postoperative use of aprotinin in cardiac operations: An alternative to its prophylactic use  Sertaç Ciçek, MD*, Ufuk Demirkiliç, MD, Ertugrul Özal, MD,

Postoperative use of aprotinin in cardiac operations: An alternative to its prophylactic use  Sertaç Ciçek, MD*, Ufuk Demirkiliç, MD, Ertugrul Özal, MD,
Efficacy and Safety of Aprotinin Use for Reoperative Valvular Surgery

Efficacy and Safety of Aprotinin Use for Reoperative Valvular Surgery
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits  Yukinori Sakao, MD, Osamu Kajikawa, PhD, Thomas R Martin,

Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits  Yukinori Sakao, MD, Osamu Kajikawa, PhD, Thomas R Martin,
Immunology and failure of valved allografts in children

Immunology and failure of valved allografts in children
A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,
Thomas V Bilfinger, MD, George B Stefano, PhD 

Thomas V Bilfinger, MD, George B Stefano, PhD 
Philip J Wolfson, MD  The Annals of Thoracic Surgery 

Philip J Wolfson, MD  The Annals of Thoracic Surgery 
Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study  Song Wan, MD, PhD, Jean-Louis.

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study  Song Wan, MD, PhD, Jean-Louis.
Enhancement of the leukocyte–endothelial cell interaction in collecting venules of skeletal muscle by protamine  Helmut Habazettl, MDa, Vladimir Martinek,

Enhancement of the leukocyte–endothelial cell interaction in collecting venules of skeletal muscle by protamine  Helmut Habazettl, MDa, Vladimir Martinek,
Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations  Michael J Davies, FRCS, Alison Allen, BScHons, Henry.

Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations  Michael J Davies, FRCS, Alison Allen, BScHons, Henry.
Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes 
François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD 

François Dagenais, MD, L.Conrad Pelletier, MD, Michel Carrier, MD 
Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications  Michael A Coady, MD, John A Rizzo, PhD, Graeme.

Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications  Michael A Coady, MD, John A Rizzo, PhD, Graeme.
Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization  Hiroshi Kumano, MD, PhD, Shigefumi Suehiro, MD, PhD, Koji.

Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization  Hiroshi Kumano, MD, PhD, Shigefumi Suehiro, MD, PhD, Koji.
Simvastatin Increases Neutrophil Apoptosis and Reduces Inflammatory Reaction After Coronary Surgery  Massimo Chello, MD, Amedeo Anselmi, MD, Cristiano.

Simvastatin Increases Neutrophil Apoptosis and Reduces Inflammatory Reaction After Coronary Surgery  Massimo Chello, MD, Amedeo Anselmi, MD, Cristiano.
How safe is the port access technique in minimally invasive coronary artery bypass grafting?  Selami Dogan, MD, Kai Graubitz, MD, Tayfun Aybek, MD, Mohammad.

How safe is the port access technique in minimally invasive coronary artery bypass grafting?  Selami Dogan, MD, Kai Graubitz, MD, Tayfun Aybek, MD, Mohammad.
Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only  Thierry P Carrel, MD, Mike Schwanda, MD,

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only  Thierry P Carrel, MD, Mike Schwanda, MD,
Hedi H Schreurs, Marianne J Wijers, Y

Hedi H Schreurs, Marianne J Wijers, Y

Similar presentations

Ads by Google